To aid mechanistic understanding, the expression and function of BA receptors such as FXR and GPBAR1 in CLL cells and infiltrating immune cells, and the signaling pathways activated by BAs in these cells should be evaluated. Here, GPBAR1 is linked to B-cell chronic lymphocytic leukemia.